Richard E. Clark
Impact in
- Hematology top 0.05%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
Papers in
- Hematology 199
- Chronic Myeloid Leukemia Treatments 137
- Acute Myeloid Leukemia Research 39
- Hematopoietic Stem Cell Transplantation 25
- Multiple Myeloma Research and Treatments 4
- Immunology 18
- Immunotherapy and Immune Responses 11
- Co-authors
- Munir Pirmohamed (15 shared papers)Andreas Hochhaus (15 shared papers)Alan K. Burnett (26 shared papers)Giuseppe Nicola Saglio (12 shared papers)Timothy P. Hughes (13 shared papers)Richard A. Larson (10 shared papers)Hagop M. Kantarjian (10 shared papers)Gabriel Étienne (5 shared papers)
- Journals
- Blood (59 papers)Leukemia (38 papers)British Journal of Haematology (24 papers)Haematologica (14 papers)Bone Marrow Transplantation (10 papers)
- Partner nations
- United KingdomGermanyItaly
In The Last Decade
Richard E. Clark
243 papers receiving 15.9k citations
Richard E. Clark's Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 11.8k
- Genetics 420
- Oncology 1k
- Immunology 843
- Pharmacology 393
Countries citing papers authored by Richard E. Clark
This map shows the geographic impact of Richard E. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Clark more than expected).
Fields of papers citing papers by Richard E. Clark
This network shows the impact of papers produced by Richard E. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Clark. The network helps show where Richard E. Clark may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard E. Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 Hit paper breakdown → | 2013 | 1620 |
| 2 | Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia Hit paper breakdown → | 2010 | 1387 |
| 3 | European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia Hit paper breakdown → | 2020 | 1091 |
| 4 | Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial Hit paper breakdown → | 2016 | 676 |
| 5 | 2004 | 536 | |
| 6 | 2015 | 425 | |
| 7 | European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia Hit paper breakdown → | 2016 | 401 |
| 8 | 2011 | 394 | |
| 9 | 2001 | 384 | |
| 10 | 2012 | 363 | |
| 11 | 2006 | 342 | |
| 12 | 2007 | 323 | |
| 13 | 2009 | 300 | |
| 14 | Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis Hit paper breakdown → | 2021 | 250 |
| 15 | 2015 | 245 | |
| 16 | 2007 | 233 | |
| 17 | 2016 | 229 | |
| 18 | 2001 | 219 | |
| 19 | Thrombotic microangiopathy following bone marrow transplantation. | 1994 | 213 |
| 20 | 2015 | 194 |
About Richard E. Clark
Richard E. Clark is a scholar working on Hematology, Immunology, Oncology, Molecular Biology and Genetics, having authored 246 papers that have together received 16.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (137 papers), Acute Myeloid Leukemia Research (39 papers), Hematopoietic Stem Cell Transplantation (25 papers), Drug Transport and Resistance Mechanisms (12 papers), Immunotherapy and Immune Responses (11 papers), RNA Interference and Gene Delivery (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Hematology (11.8k citations), Genetics (420 citations), Oncology (1k citations), Immunology (843 citations) and Pharmacology (393 citations). Richard E. Clark has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Munir Pirmohamed, Andreas Hochhaus, Alan K. Burnett, Giuseppe Nicola Saglio, Timothy P. Hughes, Richard A. Larson, Hagop M. Kantarjian, Gabriel Étienne, Claire Lucas and Surapol Issaragrisil. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Haematologica and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.